Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to -$546000.0.

  • Camp4 Therapeutics' Change in Account Payables fell 15041.55% to -$546000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.4 million, marking a year-over-year decrease of 26212.81%. This contributed to the annual value of $168000.0 for FY2024, which is 11506.73% up from last year.
  • Per Camp4 Therapeutics' latest filing, its Change in Account Payables stood at -$546000.0 for Q3 2025, which was down 15041.55% from -$190000.0 recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Change in Account Payables ranged from a high of $1.1 million in Q3 2024 and a low of -$1.0 million during Q2 2024
  • Moreover, its 3-year median value for Change in Account Payables was -$170000.0 (2023), whereas its average is -$67875.0.
  • Its Change in Account Payables has fluctuated over the past 5 years, first tumbled by 47066.67% in 2024, then skyrocketed by 8180.08% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Change in Account Payables (Quarter) stood at -$150000.0 in 2023, then plummeted by 470.67% to -$856000.0 in 2024, then skyrocketed by 36.21% to -$546000.0 in 2025.
  • Its Change in Account Payables stands at -$546000.0 for Q3 2025, versus -$190000.0 for Q2 2025 and $175000.0 for Q1 2025.